Search research articles
Contact Us
Filters
Showing results (191-200 of 273) with videos related to
Page
of 28
Sort By:
Frontiers in Medicine
|
November 18, 2021
Immune Checkpoint Inhibitor and Radiotherapy-Related Pneumonitis: An Informatics Approach to Determine Real-World Incidence, Severity, Management, and Resource Implications
Sumeet Hindocha, Des Campbell, Merina Ahmed, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
October 16, 2024
Assessing the sensitivity and acceptability of the Royal Marsden Palliative Care Referral "Triggers" Tool for outpatients with cancer
Laila Kamal, Yuki Kano, Anna-Marie Stevens, et al.
Cancer
|
April 16, 2013
Symptomatic reduction in free testosterone levels secondary to crizotinib use in male cancer patients
Andrew J Weickhardt, Robert C Doebele, W Thomas Purcell, et al.
Cardio-Oncology (London, England)
|
November 24, 2022
The spectrum of cardiovascular complications related to immune-checkpoint inhibitor treatment : Including myocarditis and the new entity of non inflammatory left ventricular dysfunction
Maria Sol Andres, Sivatharshini Ramalingam, Stuart D Rosen, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
April 4, 2026
Definitive Radiotherapy to the Primary Tumor in Stage IV NSCLC: A Consensus Statement From the International Association for the Study of Lung Cancer Advanced Radiation Technology Subcommittee
Ryan A McMahon, Kevin Lee Min Chua, Corinne Faivre-Finn, et al.
The Journal of Pathology
|
September 27, 2024
Genomic analysis defines distinct pancreatic and neuronal subtypes of lung carcinoid
Clara Domingo-Sabugo, Saffron Ag Willis-Owen, Amit Mandal, et al.
The Oncologist
|
March 11, 2022
Tyrosine Kinase Inhibitor Activity in Patients with NSCLC Harboring Uncommon EGFR Mutations: A Retrospective International Cohort Study (UpSwinG)
Sanjay Popat, Te-Chun Hsia, Jen-Yu Hung, et al.
Scientific Reports
|
June 15, 2021
Y disruption, autosomal hypomethylation and poor male lung cancer survival
Saffron A G Willis-Owen, Clara Domingo-Sabugo, Elizabeth Starren, et al.
British Journal of Cancer
|
December 5, 2024
Long term efficacy of first-line afatinib and the clinical utility of ctDNA monitoring in patients with suspected or confirmed EGFR mutant non-small cell lung cancer who were unsuitable for chemotherapy
Sanjay Popat, Adam Januszewski, Mary O'Brien, et al.
Nature Reviews. Clinical Oncology
|
March 15, 2025
Utilizing ctDNA to discover mechanisms of resistance to targeted therapies in patients with metastatic NSCLC: towards more informative trials
Sophie M Ernst, Mihaela Aldea, Jan H von der Thüsen, et al.
Page
of 28
Search research articles
Search
Showing results (191-200 of 273) with videos related to
Sort By:
Page
of 28
Frontiers in Medicine
|
November 18, 2021
Immune Checkpoint Inhibitor and Radiotherapy-Related Pneumonitis: An Informatics Approach to Determine Real-World Incidence, Severity, Management, and Resource Implications
Sumeet Hindocha, Des Campbell, Merina Ahmed, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
October 16, 2024
Assessing the sensitivity and acceptability of the Royal Marsden Palliative Care Referral "Triggers" Tool for outpatients with cancer
Laila Kamal, Yuki Kano, Anna-Marie Stevens, et al.
Cancer
|
April 16, 2013
Symptomatic reduction in free testosterone levels secondary to crizotinib use in male cancer patients
Andrew J Weickhardt, Robert C Doebele, W Thomas Purcell, et al.
Cardio-Oncology (London, England)
|
November 24, 2022
The spectrum of cardiovascular complications related to immune-checkpoint inhibitor treatment : Including myocarditis and the new entity of non inflammatory left ventricular dysfunction
Maria Sol Andres, Sivatharshini Ramalingam, Stuart D Rosen, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
April 4, 2026
Definitive Radiotherapy to the Primary Tumor in Stage IV NSCLC: A Consensus Statement From the International Association for the Study of Lung Cancer Advanced Radiation Technology Subcommittee
Ryan A McMahon, Kevin Lee Min Chua, Corinne Faivre-Finn, et al.
The Journal of Pathology
|
September 27, 2024
Genomic analysis defines distinct pancreatic and neuronal subtypes of lung carcinoid
Clara Domingo-Sabugo, Saffron Ag Willis-Owen, Amit Mandal, et al.
The Oncologist
|
March 11, 2022
Tyrosine Kinase Inhibitor Activity in Patients with NSCLC Harboring Uncommon EGFR Mutations: A Retrospective International Cohort Study (UpSwinG)
Sanjay Popat, Te-Chun Hsia, Jen-Yu Hung, et al.
Scientific Reports
|
June 15, 2021
Y disruption, autosomal hypomethylation and poor male lung cancer survival
Saffron A G Willis-Owen, Clara Domingo-Sabugo, Elizabeth Starren, et al.
British Journal of Cancer
|
December 5, 2024
Long term efficacy of first-line afatinib and the clinical utility of ctDNA monitoring in patients with suspected or confirmed EGFR mutant non-small cell lung cancer who were unsuitable for chemotherapy
Sanjay Popat, Adam Januszewski, Mary O'Brien, et al.
Nature Reviews. Clinical Oncology
|
March 15, 2025
Utilizing ctDNA to discover mechanisms of resistance to targeted therapies in patients with metastatic NSCLC: towards more informative trials
Sophie M Ernst, Mihaela Aldea, Jan H von der Thüsen, et al.
Page
of 28